Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A Hanson

Showing results (101-110 of 175) with videos related to

Pageof 18
Sort By:
American Journal of Clinical Pathology|October 1, 1996
Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemiaA Tefferi, B J Bartholmai, T E Witzig, et al.
Leukemia|September 14, 2011
IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromesA Pardanani, C Finke, T L Lasho, et al.
Annals of Internal Medicine|December 1, 1989
Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1)D Shibata, R K Brynes, A Rabinowitz, et al.
Leukemia|October 23, 2009
The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patientsA Pardanani, T L Lasho, C M Finke, et al.
Blood Cancer Journal|April 22, 2017
Liver function test abnormalities and their clinical relevance in primary myelofibrosisD Barraco, M Mudireddy, S Shah, et al.
Leukemia|January 30, 2010
Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsetsW G Morice, D Jevremovic, H Olteanu, et al.
British Journal of Haematology|April 12, 2001
Detection of diagnostically critical, often hidden, anomalies in complex karyotypes of haematological disorders using multicolour fluorescence in situ hybridizationS M Jalal, M E Law, J Stamberg, et al.
Blood Cancer Journal|December 29, 2017
Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patientsS Cerquozzi, D Barraco, T Lasho, et al.
British Journal of Haematology|October 1, 1989
True histiocytic lymphoma: histopathologic, immunophenotypic and genotypic analysisC A Hanson, W Jaszcz, J H Kersey, et al.
Leukemia Research|February 13, 2001
Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndromeA Tefferi, M A Elliott, D P Steensma, et al.
Pageof 18

Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
American Journal of Clinical Pathology|October 1, 1996
Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemiaA Tefferi, B J Bartholmai, T E Witzig, et al.
Leukemia|September 14, 2011
IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromesA Pardanani, C Finke, T L Lasho, et al.
Annals of Internal Medicine|December 1, 1989
Human T-cell lymphotropic virus type I (HTLV-I)-associated adult T-cell leukemia-lymphoma in a patient infected with human immunodeficiency virus type 1 (HIV-1)D Shibata, R K Brynes, A Rabinowitz, et al.
Leukemia|October 23, 2009
The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patientsA Pardanani, T L Lasho, C M Finke, et al.
Blood Cancer Journal|April 22, 2017
Liver function test abnormalities and their clinical relevance in primary myelofibrosisD Barraco, M Mudireddy, S Shah, et al.
Leukemia|January 30, 2010
Chronic lymphoproliferative disorder of natural killer cells: a distinct entity with subtypes correlating with normal natural killer cell subsetsW G Morice, D Jevremovic, H Olteanu, et al.
British Journal of Haematology|April 12, 2001
Detection of diagnostically critical, often hidden, anomalies in complex karyotypes of haematological disorders using multicolour fluorescence in situ hybridizationS M Jalal, M E Law, J Stamberg, et al.
Blood Cancer Journal|December 29, 2017
Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patientsS Cerquozzi, D Barraco, T Lasho, et al.
British Journal of Haematology|October 1, 1989
True histiocytic lymphoma: histopathologic, immunophenotypic and genotypic analysisC A Hanson, W Jaszcz, J H Kersey, et al.
Leukemia Research|February 13, 2001
Amifostine alone and in combination with erythropoietin for the treatment of favorable myelodysplastic syndromeA Tefferi, M A Elliott, D P Steensma, et al.
Pageof 18